This biotech just laid off 30% of its staff. The CEO called the move ‘counterintuitive’


A Lexington biotech is laying off nearly one-third of its workforce, and it's not for the usual reasons.

Previous WFU School of Medicine researchers receive $3.2M grant to study effects of mind-body practices on surgical outcomes
Next Sutter Health's third-quarter earnings decline as expenses rise, investments fall